|
|
Prepublished online as a Blood First Edition Paper on October 31, 2002; DOI 10.1182/blood-2002-06-1862.
Previous Article | Table of Contents | Next Article 
Blood, 1 March 2003, Vol. 101, No. 5, pp. 1784-1789
HEMATOPOIESIS
Combined effects of Notch signaling and cytokines
induce a multiple log increase in precursors with lymphoid and myeloid
reconstituting ability
Barbara Varnum-Finney,
Carolyn Brashem-Stein, and
Irwin D. Bernstein
From the Clinical Research Division, Fred Hutchinson
Cancer Research Center, Seattle, WA; and the Department of Pediatrics,
University of Washington, Seattle.
We investigated whether combined signaling induced by engineered
Notch ligands and hematopoietic growth factors influences hematopoietic
stem-cell differentiation. We show that incubation of murine marrow
precursors with Delta1ext-IgG, a Notch ligand
consisting of the Delta1 extracellular domain fused to the Fc
portion of human immunoglobulin G1 (IgG1), and growth factors
stem cell factor (SCF), interleukin 6 (IL-6), IL-11, and Flt3-l
inhibited myeloid differentiation and promoted a several-log increase
in the number of precursors capable of short-term lymphoid and myeloid
repopulation. Addition of IL7 promoted early T-cell development,
whereas addition of granulocyte-macrophage colony-stimulating factor
(GM-CSF) led to terminal myeloid differentiation. These results
support a role for combinatorial effects by Notch and cytokine-induced signaling pathways in regulating hematopoietic cell
fate and suggest the usefulness of Notch ligand in increasing hematopoietic precursor numbers for clinical stem-cell transplantation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Abdel-Azim, Y. Zhu, R. Hollis, X. Wang, S. Ge, Q.-L. Hao, G. Smbatyan, D. B. Kohn, M. Rosol, and G. M. Crooks
Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl
Blood,
April 15, 2008;
111(8):
4064 - 4074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Varnum-Finney, M. H. Dallas, K. Kato, and I. D. Bernstein
Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymus
Blood,
March 1, 2008;
111(5):
2615 - 2620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Blank, G. Karlsson, and S. Karlsson
Signaling pathways governing stem-cell fate
Blood,
January 15, 2008;
111(2):
492 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Araki, K. Yoshinaga, P. Boccuni, Y. Zhao, R. Hoffman, and N. Mahmud
Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential
Blood,
April 15, 2007;
109(8):
3570 - 3578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Dallas, B. Varnum-Finney, P. J. Martin, and I. D. Bernstein
Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1
Blood,
April 15, 2007;
109(8):
3579 - 3587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Cheng, Y. Nefedova, C. A. Corzo, and D. I. Gabrilovich
Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands
Blood,
January 15, 2007;
109(2):
507 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Garcia-Peydro, V. G. de Yebenes, and M. L. Toribio
Notch1 and IL-7 Receptor Interplay Maintains Proliferation of Human Thymic Progenitors while Suppressing Non-T Cell Fates
J. Immunol.,
September 15, 2006;
177(6):
3711 - 3720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Calvi
Hematopoietic-Osteoblastic Interactions in the Hematopoietic Stem Cell Niche
IBMS BoneKEy,
May 1, 2006;
3(5):
10 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. de Pooter, T. M. Schmitt, J. L. de la Pompa, Y. Fujiwara, S. H. Orkin, and J. C. Zuniga-Pflucker
Notch Signaling Requires GATA-2 to Inhibit Myelopoiesis from Embryonic Stem Cells and Primary Hemopoietic Progenitors
J. Immunol.,
May 1, 2006;
176(9):
5267 - 5275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Huang, K. P. Garrett, R. Pelayo, J. C. Zuniga-Pflucker, H. T. Petrie, and P. W. Kincade
Propensity of Adult Lymphoid Progenitors to Progress to DN2/3 Stage Thymocytes with Notch Receptor Ligation
J. Immunol.,
October 15, 2005;
175(8):
4858 - 4865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Delaney, B. Varnum-Finney, K. Aoyama, C. Brashem-Stein, and I. D. Bernstein
Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells
Blood,
October 15, 2005;
106(8):
2693 - 2699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Burns, D. Traver, E. Mayhall, J. L. Shepard, and L. I. Zon
Hematopoietic stem cell fate is established by the Notch-Runx pathway
Genes & Dev.,
October 1, 2005;
19(19):
2331 - 2342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Maeda, Y. Baba, Y. Nagai, K. Miyazaki, A. Malykhin, K. Nakamura, P. W. Kincade, N. Sakaguchi, and K. M. Coggeshall
IL-6 blocks a discrete early step in lymphopoiesis
Blood,
August 1, 2005;
106(3):
879 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Sarmento, H. Huang, A. Limon, W. Gordon, J. Fernandes, M. J. Tavares, L. Miele, A. A. Cardoso, M. Classon, and N. Carlesso
Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation
J. Exp. Med.,
July 5, 2005;
202(1):
157 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Dallas, B. Varnum-Finney, C. Delaney, K. Kato, and I. D. Bernstein
Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells
J. Exp. Med.,
May 2, 2005;
201(9):
1361 - 1366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. C. Mancini, N. Mantei, A. Dumortier, U. Suter, H. R. MacDonald, and F. Radtke
Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation
Blood,
March 15, 2005;
105(6):
2340 - 2342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Hadland, S. S. Huppert, J. Kanungo, Y. Xue, R. Jiang, T. Gridley, R. A. Conlon, A. M. Cheng, R. Kopan, and G. D. Longmore
A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development
Blood,
November 15, 2004;
104(10):
3097 - 3105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Vas, L. Szilagyi, K. Paloczi, and F. Uher
Soluble Jagged-1 is able to inhibit the function of its multivalent form to induce hematopoietic stem cell self-renewal in a surrogate in vitro assay
J. Leukoc. Biol.,
April 1, 2004;
75(4):
714 - 720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Cheng, Y. Nefedova, L. Miele, B. A. Osborne, and D. Gabrilovich
Notch signaling is necessary but not sufficient for differentiation of dendritic cells
Blood,
December 1, 2003;
102(12):
3980 - 3988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Klarmann, M. Ortiz, M. Davies, and J. R. Keller
Identification of in vitro growth conditions for c-Kit-negative hematopoietic stem cells
Blood,
November 1, 2003;
102(9):
3120 - 3128.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|